When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.
As part of a regular review of safety reports for the vaccine, the European Medicines Agency’s safety committee is analysing data provided on cases of Guillain-Barre syndrome, the regulator said.
It comes as some European countries have restricted use of the AstraZeneca jab to older age groups, citing the risks of rare blood clots in younger people.
MORE TO FOLLOW
Source: Read Full Article